Press releases

Regulatory press release 2020-11-20

Xspray Pharma publishes Interim Report Q3, January – September 2020

Regulatory press release 2020-10-30

Number of shares and votes in Xspray

Press release 2020-10-21

Xspray Pharma’s Nomination Committee for the Annual General Meeting 2021

Regulatory press release 2020-10-20

Xspray Pharma Has Carried Out a Directed Share Issue Raising Gross Proceeds of Approximately SEK 265 million

Regulatory press release 2020-10-20

Xspray Pharma Contemplates a Directed Share Issue

All press releases

Latest report
Interim Report Q3 2020
Subscribe
Get our latest press releases and reports
Subscribe
Submit to our press releases and get an email every time we publish a press release or report on our website.
Type*
Reports
Press releases
E-mail*

Välj språk*
Swedish
English
When clicked on Send I agree that my personal information will be saved. Read more
Email
This field is for validation purposes and should be left unchanged.

Press contact

Per Andersson, CEO

+46 (0)8 730 37 00

per.andersson@xspray.com

Presentations and interviews

Interview with CEO Per Andersson at Redeye 29 september, 2020

Interview with CEO Per Andersson at Redeye 24 August 2020

Audiocast: Comment on BE-study result, August 13, 2020

Media